Molecular Mechanisms of Estrogen Action: Selective Ligands and Receptor Pharmacology
Abstract
Estrogens exert profound effects on the physiology of diverse target cells and these effects appear to be mediated by two estrogen receptor (ER) subtypes, ERalpha and ERbeta. We have investigated how ER ligands, ranging from pure agonists to antagonists, interact with ERalpha and ERbeta, and regulate their transcriptional activity on different genes. Mutational mapping-structure activity studies indicate that different residues of the ER ligand binding domain are involved in the recognition of structurally distinct estrogens and antiestrogens. We have identified from ligands of diverse structure, several particularly interesting ones that are high potency selective agonists via ERalpha and others that are full agonists through ERalpha while being full antagonists through ERbeta. Antiestrogens such as hydroxytamoxifen, which are mixed agonist/antagonists through ERalpha, are pure antagonists through ERbeta at estrogen response element-containing gene sites. Studies with ERalpha/beta chimeric proteins reveal that tamoxifen agonism requires the activation function 1 region of ERalpha. Through two-hybrid assays, we have isolated an ER-specific coregulator that potentiates antiestrogen antagonist effectiveness and represses ER transcriptional activity. We have also focused on understanding the distinct pharmacologies of antiestrogen- and estrogen-regulated genes. Although antiestrogens are thought to largely act by antagonizing the actions of estrogens, we have found among several new ER-regulated genes, quinone reductase (QR), a detoxifying phase II antioxidant enzyme, that has its activity up-regulated by antiestrogens in an ER-dependent manner in breast cancer cells. This response is antagonized by estrogens, thus showing 'reversed pharmacology'. Increased QR activity by antiestrogens requires a functional ER (ERalpha or ERbeta) and is, interestingly, mediated via the electrophile response element in the QR gene 5' regulatory region. The up-regulation of QR may contribute to the beneficial effects of tamoxifen, raloxifene, and other antiestrogens in breast cancer prevention and treatment. Estrogens rapidly up-regulate expression of several genes associated with cell cytoarchitectural changes including NHE-RF, the sodium hydrogen exchanger regulatory factor, also known as EBP50. NHE-RF/EBP50 is enriched in microvilli, and may serve as a scaffold adaptor protein in regulating early changes in cell architecture and signal transduction events induced by estrogen. Analyses of the regulatory regions of these primary response genes, and the antioxidant and other signaling pathways involved, are providing considerable insight into the mechanisms by which ligands, that function as selective estrogen receptor modulators or SERMs, exert their marked effects on the activities and properties of target cells. The intriguing biology of estrogens in its diverse target cells is thus determined by the structure of the ligand, the ER subtype involved, the nature of the hormone-responsive gene promoter, and the character and balance of coactivators and corepressors that modulate the cellular response to the ER-ligand complex. The continuing development of ligands that function as selective estrogens or antiestrogens for ERalpha or ERbeta should allow optimized tissue selectivity of these agents for menopausal hormone replacement therapy and the treatment and prevention of breast cancer.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Phytoecdysteroids influence signal transduction through membrane-bound receptors, particularly estrogen receptors (alpha and beta).
“Phytoecdysteroids influence signal transduction through membrane-bound receptors, particularly estrogen receptors (alpha and beta) [65,66].”
From Phytoecdysteroids: Quantification in Selected Plant Species and Evaluation of Some Effects on Gastric Smooth Muscles (2024) · cites this paper as [65]
Cites
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964 · see citing works
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G. J. M., Enmark, E., Pelto‐Huikko, M., Nilsson, S., & Gustafsson, J.-Α. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,792 · see citing works
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442 · see citing works
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355 · see citing works
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269 · see citing works
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045 · see citing works
Lubahn, D. B., Moyer, J. S., GOLDING, T. S., Couse, J. F., Korach, K. S., & Smithies, O. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11162 · Cited by 1,901 · see citing works
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861 · see citing works
Generation and reproductive phenotypes of mice lacking estrogen receptor β
Krege, J. H., Hodgin, J. B., Couse, J. F., Enmark, E., Warner, M. N., Mahler, J. F., Sar, M., Korach, K. S., Gustafsson, J.-Α., & Smithies, O. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15677 · Cited by 1,692 · see citing works
Razandi, M., Pedram, A., Greene, G. L., & Levin, E. R. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.2.0239 · Cited by 1,046 · see citing works
Tyrosine kinase/p21ras/MAP‐kinase pathway activation by estradiol‐receptor complex in MCF‐7 cells.
Migliaccio, A., Domenico, M. D., Castoria, G., de Falco, A., Bontempo, P., Nola, E., & Auricchio, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00471.x · Cited by 950 · see citing works
Nuclear receptor coactivators and corepressors
Horwitz, K. B., Jackson, T. A., Bain, D. L., Richer, J. K., Takimoto, G. S., & Tung, L. W. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.10.9121485 · Cited by 943 · see citing works
Berry, M., METZGER, D., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07469.x · Cited by 760 · see citing works
Tzukerman, M., Esty, A., Santiso‐Mere, D., Danielian, P. S., Parker, M. G., Stein, R. B., Pike, J. W., & McDonnell, D. P. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.1.8152428 · Cited by 671 · see citing works
Katzenellenbogen, J., O'Malley, B., & Katzenellenbogen, B. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.2.8825552 · Cited by 537 · see citing works
Self-citationEstrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.358 · Cited by 532 · see citing works
Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata, H., Spencer, T. E., Oñate, S. A., Jenster, G. W., Tsai, M., Tsai, M., & O’Malley, B. W. (1997) · PubMed · Cited by 520 · see citing works
Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
Iafrati, M. D., Karas, R. H., Aronovitz, M. A., Kim, S., Sullivan, T. R., Lubahn, D. B., O’Donnell, T. F. X., Korach, K. S., & Mendelsohn, M. E. (1997) · Nature Medicine · doi:10.1038/nm0597-545 · Cited by 486 · see citing works
Endocrine Pharmacology of Antiestrogens as Antitumor Agents*
Jordan, V. C., & Murphy, C. S. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-4-578 · Cited by 406 · see citing works
Endocrine treatment of breast cancer in women
SANTEN, R. J., MANNI, A., HARVEY, H., & REDMOND, C. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-221 · Cited by 399 · see citing works
Razandi, M. (1999) · Molecular Endocrinology · doi:10.1210/me.13.2.307 · Cited by 385 · see citing works
Estrogen Receptors: Bioactivities and Interactions with Cell Signaling Pathways1
Katzenellenbogen, B. S. (1996) · Biology of Reproduction · doi:10.1095/biolreprod54.2.287 · Cited by 369 · see citing works
Self-citationImprota-Brears, T., Whorton, A. R., Codazzi, F., York, J. D., Meyer, T., & McDonnell, D. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4686 · Cited by 342 · see citing works
Sun, J., Meyers, M. J., Fink, B. E., Rajendran, R. R., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1999) · Endocrinology · doi:10.1210/endo.140.2.6480 · Cited by 315 · see citing works
Self-citationMontano, M. M., Ekena, K., Delage-Mourroux, R., Chang, W., Martini, P. G. V., & Katzenellenbogen, B. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6947 · Cited by 297 · see citing works
Self-citationZhang, Q., Borg, Å., Wolf, D. M., Oesterreich, S., & Fuqua, S. A. W. (1997) · PubMed · Cited by 286 · see citing works
McInerney, E. M., Weis, K. E., Sun, J., Mosselman, S., & Katzenellenbogen, B. S. (1998) · Endocrinology · doi:10.1210/endo.139.11.6298 · Cited by 269 · see citing works
Self-citationMontano, M. M., Müller, V., Trobaugh, A., & Katzenellenbogen, B. S. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.7.7476965 · Cited by 246 · see citing works
Self-citationWeis, K. E., Ekena, K., Thomas, J. A., Lazennec, G., & Katzenellenbogen, B. S. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.11.8923465 · Cited by 236 · see citing works
Self-citationKraus, W. L., McInerney, E. M., & Katzenellenbogen, B. S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12314 · Cited by 208 · see citing works
Self-citationWrenn, C. K., & Katzenellenbogen, B. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80497-9 · Cited by 185 · see citing works
Self-citationAntiestrogens: Mechanisms of action and resistance in breast cancer
Katzenellenbogen, B. S., Montano, M. M., Ekena, K., et al. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005835428423 · Cited by 182 · see citing works
Self-citationLieberherr, M., Grosse, B., Kachkache, M., & BALSAN, S. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650081111 · Cited by 174 · see citing works
Montano, M. M., & Katzenellenbogen, B. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2581 · Cited by 164 · see citing works
Self-citationExpression of estrogen receptor alpha and beta during mouse embryogenesis
Lemmen, J. G., Broekhof, J. L. M., Kuiper, G. G. J. M., Gustafsson, J.-Å., van der Saag, P. T., & van der Burg, B. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(98)00223-8 · Cited by 146 · see citing works
Editorial: A New Actor in the Estrogen Receptor Drama—Enter ER-β
Katzenellenbogen, B. S., & Korach, K. S. (1997) · Endocrinology · doi:10.1210/endo.138.3.5080 · Cited by 146 · see citing works
Self-citationNuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses
Katzenelienbogen, J. A., & Katzenellenbogen, B. S. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90143-x · Cited by 145 · see citing works
Self-citationMeyers, M. J., Sun, J., Carlson, K. E., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990101b · Cited by 137 · see citing works
Self-citationMontano, M. M., Jaiswal, A. K., & Katzenellenbogen, B. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25443 · Cited by 134 · see citing works
Self-citationLigand‐independent activation of the oestrogen receptor by mutation of a conserved tyrosine
White, R., Sjöberg, M., Kalkhoven, E., & Parker, M. G. (1997) · The EMBO Journal · doi:10.1093/emboj/16.6.1427 · Cited by 124 · see citing works
Human estrogen receptor mutants with altered estrogen and antiestrogen ligand discrimination.
Pakdel, F., & Katzenellenbogen, B. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50749-9 · Cited by 121 · see citing works
Self-citationHarlow, K. W., Smith, D. N., Katzenellenbogen, J. A., Greene, G. L., & Katzenellenbogen, B. S. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71519-6 · Cited by 120 · see citing works
Self-citationPowerful dominant negative mutants of the human estrogen receptor
Ince, B. A., Zhuang, Y., Wrenn, C. K., Shapiro, D. J., & Katzenellenbogen, B. S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85204-3 · Cited by 117 · see citing works
Self-citationEkena, K., Weis, K. E., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.20053 · Cited by 113 · see citing works
Self-citationEstrogen Receptor Regulation of the Na+/H+ Exchanger Regulatory Factor*
Ediger, T. R., Kraus, W. L., Weinman, E. J., et al. (1999) · Endocrinology · doi:10.1210/endo.140.7.6885 · Cited by 105 · see citing works
Self-citationReese, J. C., & Katzenellenbogen, B. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99101-5 · Cited by 100 · see citing works
Self-citationSun, J. (1999) · Endocrinology · doi:10.1210/en.140.2.800 · Cited by 92 · see citing works
Self-citationLazennec, G., Ediger, T. R., Petz, L. N., Nardulli, A. M., & Katzenellenbogen, B. S. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.9.9983 · Cited by 90 · see citing works
Self-citationDeterminants of Ligand Specificity of Estrogen Receptor-α: Estrogen versus Androgen Discrimination
Ekena, K., Katzenellenbogen, B. S., & Katzenellenbogen, B. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.2.693 · Cited by 78 · see citing works
Self-citationPakdel, F., Reese, J. C., & Katzenellenbogen, B. S. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.11.8114756 · Cited by 77 · see citing works
Self-citationEkena, K., Weis, K. E., Katzenellenbogen, B. S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.5069 · Cited by 77 · see citing works
Self-citationTremblay, G. B., Tremblay, A., Labrie, F., & Giguère, V. (1998) · PubMed · Cited by 75 · see citing works
Katzenellenbogen, B. S., Bhardwaj, B., Fang, H., Ince, B. A., Pakdel, F., Reese, J. C., Schodin, D. J., & Wrenn, C. K. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90055-2 · Cited by 74 · see citing works
Self-citationAnalysis of Mechanisms That Determine Dominant Negative Estrogen Receptor Effectiveness
Schodin, D. J., Yao, Z., Shapiro, D. J., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31163 · Cited by 73 · see citing works
McInerney, E. M. (1998) · Endocrinology · doi:10.1210/en.139.11.4513 · Cited by 69 · see citing works
Lazennec, G., Alcorn, J. L., & Katzenellenbogen, B. S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0318 · Cited by 63 · see citing works
Self-citationZheng, J., & Ramirez, V. D. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00037-x · Cited by 62 · see citing works
Ince, B. A., Schodin, D. J., Shapiro, D. J., et al. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628351 · Cited by 42 · see citing works
Reese, J. C., Wooge, C. H., & Katzenellenbogen, B. S. (1992) · Molecular Endocrinology · doi:10.1210/mend.6.12.1491695 · Cited by 39 · see citing works
Self-citationEditorial: A New Actor in the Estrogen Receptor Drama--Enter ER-
Katzenellenbogen, B. S. (1997) · Endocrinology · doi:10.1210/en.138.3.861 · Cited by 38 · see citing works
Self-citationEstrogen Receptor Regulation of the Na+/H+ Exchanger Regulatory Factor
Ediger, T. R. (1999) · Endocrinology · doi:10.1210/en.140.7.2976 · Cited by 31 · see citing works
Self-citationLazennec, G. (1999) · Molecular Endocrinology · doi:10.1210/me.13.6.969 · Cited by 20 · see citing works
Reese, J. C. (1992) · Molecular Endocrinology · doi:10.1210/me.6.12.2160 · Cited by 20 · see citing works
Ince, B. A. (1995) · Endocrinology · doi:10.1210/en.136.8.3194 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cobb, J. A., O’Neill, K., Milner, J., Mahajan, G. J., Lawrence, T. J., May, W. L., Miguel-Hidalgo, J., Rajkowska, G., & Stockmeier, C. A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.12.044 · Cited by 254 · see citing works
Selective estrogen receptor-β activation stimulates skeletal muscle growth and regeneration
Velders, M., Schleipen, B., Fritzemeier, K. H., Zierau, O., & Diel, P. (2012) · The FASEB Journal · doi:10.1096/fj.11-194779 · Cited by 162 · see citing works
The Phytochemical, Biological, and Medicinal Attributes of Phytoecdysteroids: An Updated Review
Das, N., Mishra, S. K., Bishayee, A., Ali, E. S., & Bishayee, A. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.10.012 · Cited by 115 · see citing works
Parr, M. K., Zhao, P., Haupt, O., Ngueu, S. T., Hengevoss, J., Fritzemeier, K. H., Piechotta, M., Schlörer, N., Muhn, P., Zheng, W., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300806 · Cited by 106 · see citing works
Sun, J., Nawaz, Z., & Slingerland, J. M. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0082 · Cited by 83 · see citing works
Self-citationZaghloul, E., Handousa, H., Singab, A. N. B., Elmazar, M. M., Ayoub, I. M., & Swilam, N. (2023) · Plants · doi:10.3390/plants12010206 · Cited by 11 · see citing works
Todorova, V., Ivanova, S., Yotov, V., Zaytseva, E., Ardasheva, R., Turiyski, V., Prissadova, N., & Ivanov, K. (2024) · Molecules · doi:10.3390/molecules29215145 · Cited by 7 · see citing works
- Authors
- Katzenellenbogen, B. S., Choi, I., Delage-Mourroux, R., Ediger, T. R., Martini, P. G. V., Montano, M., Sun, J., Weis, K., & Katzenellenbogen, J. A.
- Affiliations
- University of Illinois Urbana-Champaign (US)
- Corresponding author
- Katzenellenbogen, Benita S
- ORCID
- Venue
- The Journal of Steroid Biochemistry and Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2000-11
- Volume
- 74
- Issue
- 5
- Pages
- 279-285
- ISSN
- 0960-0760 (ISSN-L)
- OpenAlex
- W2023314887
- Cited by
- 289
- References
- 64
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 5 · 2019: 12 · 2018: 9 · 2017: 11 · 2016: 6 · 2015: 9 · 2014: 15 · 2013: 6 · 2012: 11
- FWCI
- 1.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Steroid Biochemistry and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ca060514-10)
- National Cancer Institute (CA 18119, CA 60514)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK15556)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Keywords
- estrogen receptor, estrogen receptor alpha, estrogen receptor beta, selective estrogen receptor modulators, antiestrogens, tamoxifen, 4-hydroxytamoxifen, raloxifene, ligand-binding domain, structure-activity relationship, activation functions, coregulators, quinone reductase, antioxidant response element, breast cancer, estrogen response element, transcriptional regulation
- MeSH terms
- Estrogen Antagonists, Estrogens, Female, Gene Expression Regulation, Humans, Ligands, Receptors, Estrogen, Structure-Activity Relationship, Substrate Specificity, Selective Estrogen Receptor Modulators, Estrogen Receptor Modulators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
